Current Approaches in the Treatment of Advanced Melanoma
Melanoma is the third most common cutaneous malignancy after basal cell carcinoma and squamous cell carcinoma. Melanoma is the fifth most common malignancy in males and the sixth most common malignancy in females. The treatment modalities currently used for melanoma include surgery, immunotherapy, targeted therapy, and chemotherapy. This activity highlights the role of interprofessional team in caring for patients with melanoma.
Target Audience
This activity has been designed to meet the educational needs of physicians.
Learning Objectives
Describe the evaluation of a patient with suspected melanoma.
Contrast the roles of the various treatment modalities for melanoma, such as surgery, radiation, and chemotherapy.
Explain the role of immune checkpoint inhibitors and BRAF targeted therapy for melanoma.
Outline how a well-coordinated, interprofessional team approach provides effective care to patients affected by melanoma.
Ryan M. Weight, DO, MS
Disclosure: There are no relevant financial relationships to report for those individuals in a position to control the content of this CME Activity
Accreditation: The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.
Available Credit
- 1.00 AMA PRA Category 1 Credit™HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HCA Healthcare Continental Division designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 Attendance
- Register for the activity and create a profile including login/password.
- Review the required accreditation information: Target audience, learning objectives, and disclosure information.
- Complete the entire activity.
- Complete the post-test assessments.
- Successfully pass the post-test with a minimum score of 70%.
- Complete the evaluation survey.
- Obtain a certificate.